Cholecystokinin antagonists: anxiolytic drugs of the future
Bourin, M.; Bradwejn, J.
Pathologie-Biologie 40(3): 215-217
1992
ISSN/ISBN: 0369-8114 PMID: 1608663 Document Number: 399802
Document emailed within 1 workday
Related Documents
Crespi, F. 1998: The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats Methods and Findings in Experimental and Clinical Pharmacology 20(8): 679-697Filip, M.; Baran, L.; Siwanowicz, J.; Chojnacka-Wójcik, E.; Przegaliński, E. 1992: The anxiolytic-like effects of 5-hydroxytryptamine3 (5-HT3) receptor antagonists Polish Journal of Pharmacology and Pharmacy 44(3): 261-269
Makovec, F.; Bani, M.; Cereda, R.; Chisté, R.; Pacini, M.A.; Revel, L.; Rovati, L.A.; Rovati, L.C.; Setnikar, I. 1987: Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists Arzneimittel-Forschung 37(11): 1265-1268
Crawley, J.N.; Stivers, J.A.; Hommer, D.W.; Skirboll, L.R.; Paul, S.M. 1986: Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide Journal of Pharmacology and Experimental Therapeutics 236(2): 320-330
Evans, B.E. 1991: Molecular design of potent specific antagonists for the gastrin and cholecystokinin receptors Zeitschrift für Gastroenterologie. Verhandlungsband 26: 269-271
Bakka, A.; Johnsen, A.; Rugstad, H.E. 1974: Consumption of anxiolytic drugs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(27): 1659-1660
Wiśniewska, R.J. 1998: Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A Polish Journal of Pharmacology 50(3): 203-212
Goudemand, M.; Thomas, P. 1993: Anxiolytic drugs. Principles and rules of use La Revue du Praticien 43(5): 641-645
Sterlin, C.; Ban, T.A.; Jarrold, L. 1972: The place of doxepin among the anxiolytic-sedative drugs Current Therapeutic Research 14(4): 195-204
Pélissolo, A.; Boyer, P.; Lépine, J.P.; Bisserbe, J.C. 1996: Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world L'Encephale 22(3): 187-196
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Krsiak, M.; Sulcova, A.; Donat, P.; Tomasikova, Z.; Dlohozkova, N.; Kosar, E.; Masek, K. 1984: Can social and agonistic interactions be used to detect anxiolytic activity of drugs? Progress in Clinical and Biological Research 167: 93-114
Krsiak, M. 1974: Isolation-induced timidity in mice as a measure of anxiolytic activity of drugs Activitas Nervosa Superior 16(4): 241-242
Gomita, Y.; Moriyama, M.; Ichimaru, Y.; Araki, H.; Sagara, H. 2004: Effects of anxiolytic drugs on rewarding and aversive behaviors induced by intracranial stimulation Nihon Shinkei Seishin Yakurigaku Zasshi 24(3): 111-118
Curry, S.H. 1989: Lactate-lowering effect of dichloroacetic acid: a model for investigation of anxiolytic drugs? Psychopharmacology Bulletin 25(2): 202-203
Villani, P.; Morciano, C.; Ambrosi, P.; Brondino-Riquier, R.; Bertault-Peres, P.; Penot-Ragon, C.; Bouvenot, G. 2001: Prescriptions and consumption of hypnotic and anxiolytic drugs in the South University Hospital of Marseille Therapie 56(1): 11-14
Rodriguez, M.; Lignon, M.F.; Galas, M.C.; Amblard, M.; Martinez, J. 1990: Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors Molecular Pharmacology 38(3): 333-341
Lilja, P.; Fagan, C.J.; Wiener, I.; Inoue, K.; Watson, L.C.; Rayford, P.L.; Thompson, J.C. 1982: Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size Gastroenterology 83(1 Pt 2): 256-261
Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123
Stewart, J.M. 1994: The present and future of bradykinin antagonists Brazilian Journal of Medical and Biological Research 27(8): 1699-1706